HEALTH RESEARCH PROGRAMME CONSORTIA (RPCS): FILLING THE GAPS IN EVIDENCE: BUILDING STRONGER AND MORE RESILIENT HEALTH SYSTEMS - LOT 2 (EQUAL)

Tender description

The UK is seen as a leader in health research and a higher level of UK involvement will add value to global research efforts. FCDO (DFID) has committed to the production and use of high quality evidence, data and innovation to accelerate progress towards the Global Goals. The following areas were identified as being gaps and an opportunity for the UK to intervene, given our relative strengths: (i) Tackling infectious diseases (ii) Building stronger and more resilient health systems, (iii) Improving the health of the world's most vulnerable, including sexual and reproductive health, mental health and maternal, newborn and child health. Lot 1: The goal of the Filling the Gaps in Evidence portfolio of RPCs is to produce high quality evidence that improves the health of the poorest and most vulnerable people in developing countries. The purpose of this component is to generate new knowledge on how to address marginalisation or exclusion of vulnerable groups. The UK is firmly committed to the "Leave no-one behind" agenda. For development gains to be achieved, concerted efforts must be made to reach the poorest and most marginalised. Groups at risk may include people with disabilities, women, children and adolescents and conflict affected populations. Research submissions are expected to include a gender and disability lens i.e. how has the programme design taken into consideration how people with disabilities/men/women are impacted by the issue being researched? What are the different barriers they face? How will the research contribute to an evidence base on how to address these issues? An intersectional lens is critical to better understand the issues. Proposals can address any one or more of the following areas: • Mental Health • Sexual and Reproductive Health Rights • Maternal and Newborn Child Health • Improving health outcomes for vulnerable groups Additional information: PO8397 was the tender process for a lotted procurement following the Reg 14 Research Exemption which resulted in 7 individual contracts across three lots, previous TED Contract Award Notice - OJ S: 2021/S 057-145367 provides the detail for 6 of these contracts (PO8610, PO8611, PO8612, PO8614. PO8615, PO8616 - with this Contract Award Notice solely for PO8613. There is also a TED Contract Award Notice - OJ S: 2021-091485 replicating this notice for PO8613.